Por: The Hill Health November 15, 2022
In another example of how some people have too much money, an auction bidder purchased an old pair of over the weekend. In health news, Moderna said its updated COVID vaccine gives a strong immune response against omicron subvariants. We’ll also look at an extension in the federal health emergency for the coronavirus. and . Thank you for signing up! Subscribe to more newsletters The latest in politics and policy. Direct to your inbox.... + full article
Portland Press Herald USA World September 13, 2023
Moderna said a reformulated version of its messenger-RNA-based flu shot met its primary goals in a final-stage trial – a result that could pave the way for the company to seek regulatory approval for the influenza vaccine. In a trial on over 2,400 adults, the reformulated shot... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Fox Business USA Business March 11, 2023
Check out what's clicking on FoxBusiness.com has revealed it will add to its workforce and its U.S. office footprint. In a put out Friday, Moderna said it will add about 2,000 new employees around the world.Moderna’s hiring efforts seemingly contrast with the reductions... + más
Moderna’s Covid Boom Is Ending. Why the Outlook Isn’t All Grim. | MarketWatch
MarketWatch USA Business February 28, 2023
The earnings announcement was a sort of rubber-hits-the-road moment for Moderna (ticker: MRNA), as investors, who have been generally anticipating a drop in Covid-19 vaccine sales ever since the jab first was authorized late 2020, for the first time could fully reckon what it... + más
Associated Press USA Health February 23, 2023
Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment.Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its... + más
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
About iurex | Privacy Policy | Disclaimer |